Jiangsu Changyida Medical Technology Co., Ltd. (Neulive)

Jiangsu Changyida Medical Technology Co., Ltd. (operating as Neulive) is a China-based medical technology company focused on the research, development, production, and sales of high-end interventional medical devices and neuromodulation systems for the neuroscience field. The company aims to be a leader in the Chinese neuroscience market by providing comprehensive solutions for stroke, hemorrhage, and neurological disorders. Their product portfolio includes stroke and hemorrhage management devices such as dense mesh stents, aspiration devices, catheters, and guide wires, as well as advanced neuromodulation systems like implantable rechargeable deep brain stimulation (DBS) systems. The company maintains R&D centers in Shanghai and California and is actively involved in clinical trials for its neuro-interventional and neuromodulation technologies.